Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Mitchell

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Cancer Letters|June 17, 2006
BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trialZsofia Kote-Jarai, Trevor J Powles, Gillian Mitchell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriersYoland C Antill, Gillian Mitchell, Sandra A Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
A role for common genomic variants in the assessment of familial breast cancerSarah Sawyer, Gillian Mitchell, Joanne McKinley, et al.
Asia-Pacific Journal of Clinical Oncology|October 9, 2018
Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providersLyon Mascarenhas, Susan Shanley, Gillian Mitchell, et al.
Plos One|June 26, 2015
Breast Tissue Composition and Immunophenotype and Its Relationship with Mammographic Density in Women at High Risk of Breast CancerJia-Min B Pang, David J Byrne, Elena A Takano, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Synthetic lethality between CCNE1 amplification and loss of BRCA1Dariush Etemadmoghadam, Barbara A Weir, George Au-Yeung, et al.
BMC Cancer|July 31, 2012
How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancerKaaren J Watts, Bettina Meiser, Gillian Mitchell, et al.
Familial Cancer|February 14, 2015
Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk featuresPaul A James, Sarah Sawyer, Samantha Boyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2012
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study GroupKathryn Alsop, Sian Fereday, Cliff Meldrum, et al.
Journal of Medical Genetics|November 5, 2015
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer familiesJun Li, Huong Meeks, Bing-Jian Feng, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Cancer Letters|June 17, 2006
BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trialZsofia Kote-Jarai, Trevor J Powles, Gillian Mitchell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriersYoland C Antill, Gillian Mitchell, Sandra A Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
A role for common genomic variants in the assessment of familial breast cancerSarah Sawyer, Gillian Mitchell, Joanne McKinley, et al.
Asia-Pacific Journal of Clinical Oncology|October 9, 2018
Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providersLyon Mascarenhas, Susan Shanley, Gillian Mitchell, et al.
Plos One|June 26, 2015
Breast Tissue Composition and Immunophenotype and Its Relationship with Mammographic Density in Women at High Risk of Breast CancerJia-Min B Pang, David J Byrne, Elena A Takano, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Synthetic lethality between CCNE1 amplification and loss of BRCA1Dariush Etemadmoghadam, Barbara A Weir, George Au-Yeung, et al.
BMC Cancer|July 31, 2012
How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancerKaaren J Watts, Bettina Meiser, Gillian Mitchell, et al.
Familial Cancer|February 14, 2015
Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk featuresPaul A James, Sarah Sawyer, Samantha Boyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2012
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study GroupKathryn Alsop, Sian Fereday, Cliff Meldrum, et al.
Journal of Medical Genetics|November 5, 2015
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer familiesJun Li, Huong Meeks, Bing-Jian Feng, et al.
Pageof 12